This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in UCL's privacy notices.

Publications

Bunting EL; Hamilton J; Tabrizi SJ (2022) Polyglutamine diseases Current Opinion in Neurobiology, 72, 39-47 DOI: 10.1016/j.conb.2021.07.001
Ferreira JJ; Brogueira Rodrigues F; Duarte GS; Mestre TA; Bachoud-Levi AC; Bentivoglio AR; Burgunder JM; Cardoso F; Claassen DO; Landwehrmeyer GB (2021) A MDS Evidence-Based Review on Treatments for Huntington’s Disease Movement Disorders
Wijeratne PA; Garbarino S; Gregory S; Johnson EB; Scahill RI; Paulsen JS; Tabrizi SJ; Lorenzi M; Alexander DC (2021) Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease Neurology Genetics, 7 (5), e617-e617 DOI: 10.1212/nxg.0000000000000617
Goold R; Hamilton J; Menneteau T; Flower M; Bunting EL; Aldous SG; Porro A; Vicente JR; Allen ND; Wilkinson H (2021) FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington’s disease CELL REPORTS, 36 (9) DOI: 10.1016/j.celrep.2021.109649
Johnson EB; Ziegler G; Penny W; Rees G; Tabrizi SJ; Scahill RI; Gregory S (2021) Dynamics of Cortical Degeneration Over a Decade in Huntington’s Disease (vol 89, pg 807, 2021) BIOLOGICAL PSYCHIATRY, 90 (4), 275-275 DOI: 10.1016/j.biopsych.2021.05.020
Wijeratne PA; Johnson EB; Gregory S; Georgiou-Karistianis N; Paulsen JS; Scahill RI; Tabrizi SJ; Alexander DC (2021) A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease Frontiers in Big Data, 4 DOI: 10.3389/fdata.2021.662200
McColgan P; Helbling S; Vaculciakova L; Pine K; Wagstyl K; Attar FM; Edwards L; Papoutsi M; Wei Y; Van den Heuvel MP (2021) Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics HUMAN BRAIN MAPPING, 42 (15), 4996-5009 DOI: 10.1002/hbm.25595
Abeyasinghe PM; Long JD; Razi A; Pustina D; Paulsen JS; Tabrizi SJ; Poudel GR; Georgiou-Karistianis N (2021) Tracking Huntington & apos;s Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers MOVEMENT DISORDERS DOI: 10.1002/mds.28650
de Castro IJ; Toner B; Xie SQ; Swingland J; Hodges A; Tabrizi SJ; Turkheimer F; Pombo A; Khalil A (2021) Altered nuclear architecture in blood cells from Huntington’s disease patients. Neurological Sciences DOI: 10.1007/s10072-021-05289-w
O'Regan GC; Farag SH; Casey CS; Wood-Kaczmar A; Pocock JM; Tabrizi SJ; Andre R (2021) Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species. J Neuroinflammation, 18 (1), 94-94 DOI: 10.1186/s12974-021-02147-6